Serono  Symposia  International  Foundation  adheres  to  guidelines  of  the  European  Accreditation  Council  for  Continuing  Medical Education  (EACCME)  and  all  other  professional  organizations,  as  applicable,  which  state  that  programmes  awarding  continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the programme (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so that participants may form their own judgements, based on full disclosure of the facts. Further, all opinions and recommendations presented during the programme and  all  programme-related  materials  neither  imply  an  endorsement  nor  a  recommendation  on  the  part  of  Serono  Symposia International Foundation. All presentations represent solely the independent views of the presenters/authors.

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:

Claudio Borghi Declared receipts of grants and contract from Manarini international. Declared receipt of honoraria or consultation fees from Manarini, St. Jude medical, Servier, Berlin Chemie.  Declared to be member of a company advisory board, board of directors or other similar group of: Ely-Lilly, Menarini.  Declared participation in a company sponsored speakers’ bureau of: Menarini, Servier, St. Jude medical.

Jamshed J. Dalal Declared no potential conflict of interest.

Aniruddha Dharmadhikari Declared no potential conflict of interest.

Roberto Ferrari Declared receipt of research grant from: Boehringer Ingelheim, Novartis, Servier, Irbtech. Declared receipt of honoraria or consultation fees from: Boehringer Ingelheim, Servier. Declared participation in a company sponsored speakers’ bureau of: Boehringer Ingelheim , Servier and Merck Serono.

Guido Grassi Declared receipt of honoraria or consultation fees from: Medtronic, Boston, Scientific, Malesci. Declared participation in a company sponsored speakers’ bureau of: Medtronic.

Gao Pinjin Declared no potential conflict of interest.

Soetanto Arieska Soenarta Declared no potential conflict of interest.

Piyamitr Sritara Declared no potential conflict of interest.

Stefano Taddei Declared receipt of grants and contracts from Novartis, Servier, Boehringer.  Declared participation in a company sponsored speakers’ bureau of Servier, Stroder, Pfizer, Bayer, Msd and Boehringer.

Brian Tomlinson Declared receipts of research funding from Amgen, AstraZeneca, Bristol-Mayers Squibb, Genzyme, GlaxoSmith Kline, Merck Serono and Dohme, Novartis, Roche and Tajeda.  Declared receipt of honoraria or consultation fees from: Amgen, Janssen and Merck Serono. Declared to be member of a company advisory board, board of directors or other similar group of: Amgen, Janssen and Merck Serono. Declared participation in a company sponsored speakers’ bureau of: Merck Serono, Merck Sharp and Dohme, Ranbaxy, Servier.

Hung-Fat Tse Declared no potential conflict of interest.

The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of 18 February 2014.

Bambang Budi Siswanto

Marlon T. Co

Phrommintikul Arintaya

Lin Shuguang